Correlation between bone mineral density at different sites and diabetes peripheral neuropathy in T2DM patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400089049

Enrollment

Unknown

Registered

2024-08-30

Start date

2024-09-01

Completion date

Unknown

Last updated

2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Diabetes peripheral neuropathy group (DPN group):N/A

Non diabetes peripheral neuropathy group (non DPN group):N/A

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The selected patients need to sign informed consent; 2. The patients diagnose diabetes according to the 1999 WHO diagnostic criteria for type 2 diabetes mellitus; 3. All patients must be aged >= 18 years.

Exclusion criteria

Exclusion criteria: 1. Acute complications of recent diabetes: diabetic ketoacidosis, lactic acidosis, hyperosmolar coma, etc.; 2. Other reasons affecting bone metabolism: trauma, local inflammation or infection, abnormal parathyroid hormone, etc.; 3. Other types of diabetes: type 1 diabetes, gestational diabetes; 4. Pregnant or lactating women; 5. Patients with acute and chronic infectious diseases or cancer

Design outcomes

Primary

Measure	Time frame
Neuroelectrophysiological examination;Bone density examination;	—

Secondary

Measure	Time frame
Blood biochemistry test;	—

Countries

China

Contacts

Public ContactLingling Xu

Shenzhen Hospital, Southern Medical University

lucylingl@126.com+86 135 3883 8066

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026